Opportunity Information: Apply for CDC RFA GH11 11030501SUPP16
Apply for CDC RFA GH11 11030501SUPP16
- The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Program Expansion Supplement: Engaging Local Indigenous Partners in the Implementation and Expansion of High Quality HIV Care, Prevention and Treatment Activities in Faith-Based, Affiliated Sites in the Republic of Kenya under PEPFAR" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
- This funding opportunity was created on Jul 29, 2016.
- Applicants must submit their applications by Sep 27, 2016 Electronically submitted applications must be submitted no later than 1159 p.m., ET, on the listed application due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $5,000,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity is a PEPFAR-supported program expansion supplement administered by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (HHS/CDC), focused on strengthening and scaling high-quality HIV prevention, care, and antiretroviral treatment services in Kenya. The central idea is to provide both technical assistance and financial support to local Kenyan indigenous organizations so they can sustain, improve, and expand comprehensive HIV programming within health facilities and service delivery points that are affiliated with Faith-Based Organizations (FBOs). The opportunity is framed around long-term sustainability, meaning applicants are expected not only to deliver services, but also to build local systems and organizational capacity so services can continue reliably over time.
The program sits under the broader PEPFAR model in which CDC works alongside host-country governments and key partners to tailor support to national strategies and partnership frameworks. In Kenya, the grant emphasizes alignment with Government of Kenya priorities and close coordination with the Ministry of Health (MOH) and other GoK institutions, as well as with international and U.S. Government-funded actors. A major requirement is to avoid duplicating existing efforts and instead complement them, while also collaborating across HIV program areas when coordination would improve quality, continuity of care, or efficiency of service delivery.
Program priorities span the full continuum of HIV services. On the prevention side, the opportunity highlights the expansion of confidential counseling and testing services, including approaches that link testing to evidence-based behavior change interventions. It also emphasizes prevention of mother-to-child transmission (PMTCT) as a key prevention pillar. On the care and treatment side, the program calls for improving services for HIV/AIDS and sexually transmitted infections (STIs), strengthening management of opportunistic infections, and enhancing laboratory diagnostic capacity that supports diagnosis and ongoing clinical monitoring. Tuberculosis (TB) is specifically named as a critical intercurrent disease that must be addressed through integrated TB/HIV testing and treatment activities, reflecting the need to manage co-infections that drive illness and mortality among people living with HIV. A core expectation is supporting initiation and continuation of antiretroviral therapy (ART) and improving the quality of both pediatric and adult HIV treatment and care.
Beyond direct service delivery, the opportunity places strong weight on strengthening national and subnational capacity to collect, analyze, and use surveillance and program data. This includes expanding HIV/STI/TB surveillance activities and reinforcing laboratory systems that enable surveillance, diagnosis, treatment monitoring, and blood safety screening. The FOA also supports the development, validation, and evaluation of public health programs so that interventions can be better targeted and improved based on evidence, which can include operational or implementation-focused learning that strengthens real-world program performance.
The scope of allowable activities is broad and intentionally comprehensive, covering many standard PEPFAR service packages and related supports. Specific examples named in the announcement include PMTCT; TB/HIV testing and treatment; HIV counseling and testing approaches such as provider-initiated testing and counseling (PITC); pediatric and adult care and treatment services; nutrition programming tied to HIV care; prevention with positives (PWP) interventions that reduce onward transmission among people living with HIV; post-exposure prophylaxis (PEP); voluntary medical male circumcision (VMMC); and behavior change interventions. The intent is to expand coverage and maximize reach, while also improving service quality across these domains, particularly within FBO-affiliated networks that often serve large catchment populations and may reach communities that are harder to access through other channels.
The announcement also allows, in support of HIV service delivery, an added emphasis on other health conditions and cross-cutting public health issues where they strengthen patient outcomes or service integration. Examples listed include malaria; emerging and re-emerging infections; neglected tropical diseases; influenza and other threats with pandemic potential; environmental health issues; chronic diseases; maternal and child health; reproductive health; public health preparedness; biosafety; and injury control and prevention. This reflects a practical approach: HIV programs frequently intersect with broader clinical and public health needs, and integrated care can improve retention, adherence, and overall health outcomes for patients.
From an administrative standpoint, this is a discretionary cooperative agreement (meaning CDC is expected to have substantial involvement in the funded work, such as ongoing technical collaboration and program oversight). The opportunity number is CDC RFA GH11-11030501SUPP16 under CFDA 93.067. It was posted July 29, 2016, with an original application deadline of September 27, 2016 (electronic submissions due by 11:59 p.m. ET). The anticipated funding structure included one expected award, with an award ceiling of $5,000,000. Eligibility is listed broadly as "Others," with additional eligibility specifics referenced in the full announcement text, but the narrative focus makes clear the target implementers are local Kenyan indigenous organizations positioned to lead and expand services in FBO-affiliated settings.
In practical terms, a strong applicant under this FOA would be expected to demonstrate the ability to deliver and expand high-quality HIV services at scale, show credible plans to strengthen local organizational and workforce capacity, and present a clear coordination strategy with MOH/GoK and other partners. The proposal would also need to show how it will improve prevention impact, treatment outcomes, laboratory and surveillance performance, and overall service sustainability in faith-based affiliated sites, while using data and evaluation to continuously improve program quality and reach.
Frequently Asked Questions (FAQs)
What is this funding opportunity?
This opportunity is a PEPFAR-supported program expansion supplement administered by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (HHS/CDC). It focuses on strengthening and scaling high-quality HIV prevention, care, and antiretroviral treatment services in Kenya, with an emphasis on sustainability and long-term continuity of services.
What is the main goal of the program?
The central goal is to provide technical assistance and financial support to local Kenyan indigenous organizations so they can sustain, improve, and expand comprehensive HIV programming within health facilities and service delivery points affiliated with Faith-Based Organizations (FBOs). The program expects both service delivery and intentional capacity building so services can continue reliably over time.
Which country and service settings are targeted?
The focus is Kenya, specifically HIV service delivery within health facilities and service delivery points that are affiliated with Faith-Based Organizations (FBOs).
Who is the program designed to support as implementers?
While the eligibility category is listed broadly as "Others" (with additional details referenced in the full announcement), the narrative emphasis indicates the program is designed to support local Kenyan indigenous organizations that can lead and expand HIV services in FBO-affiliated networks.
Which U.S. agency administers the award?
The award is administered by the U.S. Centers for Disease Control and Prevention (CDC) under HHS, within the broader PEPFAR framework.
What does it mean that this is a cooperative agreement?
This is a discretionary cooperative agreement, meaning CDC is expected to have substantial involvement in the funded work. That involvement can include ongoing technical collaboration, program oversight, and close coordination during implementation.
How does this opportunity relate to PEPFAR and Government of Kenya priorities?
The opportunity sits within the PEPFAR model in which CDC works alongside host-country governments and partners to align support to national strategies and partnership frameworks. In Kenya, the grant emphasizes alignment with Government of Kenya (GoK) priorities and close coordination with the Ministry of Health (MOH) and other GoK institutions.
Is coordination with other partners required?
Yes. A major expectation is coordination with MOH/GoK and with international and U.S. Government-funded actors. Applicants are expected to avoid duplicating existing efforts, complement what already exists, and collaborate across HIV program areas when that coordination improves quality, continuity of care, or efficiency.
What HIV prevention activities are highlighted?
The prevention priorities include expanding confidential counseling and testing services, linking testing to evidence-based behavior change interventions, and emphasizing prevention of mother-to-child transmission (PMTCT) as a key prevention pillar.
What HIV counseling and testing approaches are mentioned?
The announcement specifically references confidential counseling and testing services and names provider-initiated testing and counseling (PITC) as an example of a supported approach.
Is PMTCT included in the scope of work?
Yes. Prevention of mother-to-child transmission (PMTCT) is highlighted as a key prevention pillar and is also listed among the specific examples of allowable activities.
What care and treatment priorities are included?
The program calls for improving HIV/AIDS and sexually transmitted infection (STI) services, strengthening management of opportunistic infections, enhancing laboratory diagnostic capacity for diagnosis and clinical monitoring, and supporting initiation and continuation of antiretroviral therapy (ART). It also emphasizes improving the quality of both pediatric and adult HIV treatment and care.
Does the opportunity address sexually transmitted infections (STIs)?
Yes. Improving services for HIV/AIDS and STIs is part of the care and treatment priorities, and HIV/STI surveillance is also included in the data and surveillance emphasis.
How is tuberculosis (TB) addressed in this program?
TB is explicitly identified as a critical intercurrent disease. The program expects integrated TB/HIV testing and treatment activities to address co-infection, given its impact on illness and mortality among people living with HIV.
Is antiretroviral therapy (ART) a required focus area?
ART is a core expectation. The opportunity calls for supporting initiation and continuation of ART and improving the quality of HIV treatment and care for both adults and children.
Are pediatric HIV services included?
Yes. The announcement specifically calls out improving the quality of pediatric HIV treatment and care, alongside adult services.
What laboratory-related work is supported?
The program emphasizes enhancing laboratory diagnostic capacity for diagnosis and ongoing clinical monitoring. It also supports strengthening laboratory systems for surveillance, treatment monitoring, and blood safety screening.
What surveillance and data activities are expected?
A strong emphasis is placed on strengthening national and subnational capacity to collect, analyze, and use surveillance and program data. This includes expanding HIV/STI/TB surveillance activities and reinforcing systems that enable evidence-based decision-making and program improvement.
Does the FOA support program evaluation or learning activities?
Yes. The opportunity supports development, validation, and evaluation of public health programs so interventions can be better targeted and improved based on evidence. This can include operational or implementation-focused learning to strengthen real-world performance.
What are examples of allowable activities under this opportunity?
The announcement lists a broad set of activities, including PMTCT; TB/HIV testing and treatment; HIV counseling and testing such as PITC; pediatric and adult care and treatment services; nutrition programming tied to HIV care; prevention with positives (PWP) interventions; post-exposure prophylaxis (PEP); voluntary medical male circumcision (VMMC); and behavior change interventions.
Can the program include nutrition support?
Yes. Nutrition programming tied to HIV care is explicitly named among the examples of allowable activities.
Are prevention with positives (PWP) activities allowed?
Yes. Prevention with positives (PWP) interventions aimed at reducing onward transmission among people living with HIV are listed as allowable activities.
Is post-exposure prophylaxis (PEP) included?
Yes. Post-exposure prophylaxis (PEP) is included among the specific examples of activities named in the announcement.
Is voluntary medical male circumcision (VMMC) included?
Yes. Voluntary medical male circumcision (VMMC) is listed as an example of an allowable activity under the comprehensive service scope.
Are behavior change interventions part of the scope?
Yes. The opportunity references evidence-based behavior change interventions linked to testing and also lists behavior change interventions among the allowable activities.
Is the focus only on HIV, or can other health areas be included?
The FOA allows an added emphasis on other health conditions and cross-cutting public health issues when they strengthen HIV service delivery, patient outcomes, or service integration. Examples listed include malaria; emerging and re-emerging infections; neglected tropical diseases; influenza and other threats with pandemic potential; environmental health; chronic diseases; maternal and child health; reproductive health; public health preparedness; biosafety; and injury control and prevention.
Why does the opportunity mention other diseases and public health issues?
The rationale described is practical: HIV programs frequently intersect with broader clinical and public health needs. Integrated care can improve retention in care, adherence to treatment, and overall health outcomes for patients.
What is expected regarding sustainability?
Sustainability is a central theme. Applicants are expected to deliver services while also building local systems and organizational capacity so services can continue reliably over time, particularly within FBO-affiliated sites.
What kinds of capacity building are implied by the announcement?
The announcement emphasizes strengthening local organizational and workforce capacity and improving systems such as laboratory services, surveillance, and program data use. The intent is to improve quality and reliability of services over the long term.
How many awards were anticipated?
The funding structure anticipated one expected award.
What was the award ceiling?
The award ceiling listed for the opportunity was $5,000,000.
What is the opportunity number and CFDA listing?
The opportunity number is CDC RFA GH11-11030501SUPP16, under CFDA 93.067.
When was the opportunity posted and when was the application due?
The opportunity was posted on July 29, 2016. The original application deadline was September 27, 2016, with electronic submissions due by 11:59 p.m. ET.
What would a strong applicant be expected to demonstrate?
Based on the announcement narrative, a strong applicant would demonstrate the ability to deliver and expand high-quality HIV services at scale, present credible plans to strengthen local organizational and workforce capacity, and provide a clear coordination strategy with MOH/GoK and other partners. The proposal would also be expected to show how it will improve prevention impact, treatment outcomes, laboratory and surveillance performance, and overall sustainability in FBO-affiliated sites, using data and evaluation to continuously improve quality and reach.
Browse more opportunities from the same category: Health
Next opportunity: Outreach to Support Every Kid in the Park campaign and Urban Ranger Program
Previous opportunity: Program Expansion Supplement: Support of Civil Registration and Vital Statistics in Malawi Registration Bureau under the President's Emergency Plan for AIDS Relief (PEPFAR)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH11 11030501SUPP16
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH11 11030501SUPP16) also looked into and applied for these:
| Funding Opportunity |
|---|
| Program Expansion Supplement: Public-Private Partnerships in PEPFAR Countries under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 15390201SUPP16 Funding Number: CDC RFA GH15 15390201SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $9,400,000 |
| Program Expansion Supplement for Engaging Local Indigenous Partners in the Implementation and Expansion of High Quality HIV Care, Prevention and Treatment Activities in Faith-Based, Affiliated Sites in the Republic of Kenya under PEPFAR Apply for CDC RFA GH11 11030502SUPP16 Funding Number: CDC RFA GH11 11030502SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $2,400,000 |
| Program Expansion Supplement for Support the Implementation and Expansion of High Quality HIV Care, Prevention and Treatment Activities in Central Province in the Republic of Kenya by Engaging Local Indigenous Partners under PEPFAR Apply for CDC RFA GH11 11040501SUPP16 Funding Number: CDC RFA GH11 11040501SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $3,100,000 |
| Program Expansion Supplement for Support the Implementation and Expansion of High Quality HIV Care, Prevention and Treatment Activities in Central Province in the Republic of Kenya by Engaging Local Indigenous Partners PEPFAR Apply for CDC RFA GH11 11040502SUPP16 Funding Number: CDC RFA GH11 11040502SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $1,400,000 |
| Program Expansion Supplement for Implementation of Sustainable Laboratory Quality Systems in the Republic of Kenya under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 15440201SUPP16 Funding Number: CDC RFA GH15 15440201SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $401,462 |
| Program Expansion Supplement: Supporting HIV and Tuberculosis Response in the Kingdom of Lesotho through District-based Comprehensive Prevention, Care and Treatment Program and Health Systems Strengthening under PEPFAR Apply for CDC RFA GH15 15480201SUPP16 Funding Number: CDC RFA GH15 15480201SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $388,800 |
| Program Expansion Supplement:Reducing New HIV Infections, Strengthening Health & Strategic Information Systems, Capacity Building & Increasing Access to Quality HIV/AIDS services through Support Programs Conducted by the Govt of Botswana under PEPFAR Apply for CDC RFA GH11 11970401SUPP16 Funding Number: CDC RFA GH11 11970401SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $425,000 |
| Program Expansion Supplement: Supporting Health Worker Staffing in South Africa under PEPFAR Apply for CDC RFA GH11 11100501SUPP16 Funding Number: CDC RFA GH11 11100501SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $1,360,545 |
| Program Expansion Supplement for District Health System Strengthening and Quality Improvement for Service Delivery in Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 12480401SUPP16 Funding Number: CDC RFA GH12 12480401SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $310,982 |
| Program Expansion Supplement: Strengthening the SA National Department of Health to implement and evaluate evidence-based public health program, surveillance and disease control efforts under PEPFAR Apply for CDC RFA GH13 13370501SUPP16 Funding Number: CDC RFA GH13 13370501SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $13,500,000 |
| Program Expansion Supplement: Strengthening Local Capacity to Deliver Sustainable Quality Assured Universal Coverage of Clinical HIV/TB Services and Provide Central Level Technical Assistance to the NTCP in Swaziland under PEPFAR Apply for CDC RFA GH15 15830201SUPP16 Funding Number: CDC RFA GH15 15830201SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $420,148 |
| Program Expansion Supplement: Strengthening HIV/TB Laboratory Quality Management Systems and Services in the Kingdom of Swaziland under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 15810201SUPP16 Funding Number: CDC RFA GH15 15810201SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $1,628,300 |
| Program Expansion Supplement: Improving Quality of Care and Health Impact through Sustainable, Integrated, Innovative Information System Technologies in Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 12500401SUPP16 Funding Number: CDC RFA GH12 12500401SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $500,000 |
| Program Expansion Supplement for Planning, Implementation and Evaluation of Comprehensive HIV Prevention Programs in South Africa under PEPFAR Apply for CDC RFA GH11 11520502SUPP16 Funding Number: CDC RFA GH11 11520502SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $876,491 |
| Program Expansion Supplement: Strengthening High Quality Laboratory Services Scale-up for HIV Diagnosis, Care, Treatment and Monitoring in Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 15510201SUPP16 Funding Number: CDC RFA GH15 15510201SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $1,345,600 |
| Program Expansion Supplement: Strengthening Local Capacity to Provide Sustainable HIV-Related Care and Treatment Services in South Africa Apply for CDC RFA GH11 11090501SUPP16 Funding Number: CDC RFA GH11 11090501SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $15,000,000 |
| Program Expansion Supplement: Technical Assistance Services to Countries Supported by the President's Emergency Plan for HIV/AIDS Relief (PEPFAR) and the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria Apply for CDC RFA GH13 13680302SUPP16 Funding Number: CDC RFA GH13 13680302SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $900,000 |
| National Hemophilia Program Coordinating Center Apply for HRSA 17 087 Funding Number: HRSA 17 087 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Improvement of Laboratory and Clinical Services, and Collaboration across the National HIV and TB Programs in Vietnam under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1711 Funding Number: CDC RFA GH17 1711 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $500,000 |
| Regional Hemophilia Network Apply for HRSA 17 074 Funding Number: HRSA 17 074 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH11 11030501SUPP16", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.